MedTrace Logo

Dance Program for Youth With Cerebral Palsy

NCT06100562 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-09-08

No results posted yet for this study

Summary

The goal of this prospective cohort study is to learn about the impact of an adapted dance program in youth with cerebral palsy. The main questions it aims to answer are:

1. Are there clinically significant benefits for children with cerebral palsy who participate in an Adaptive Dance Program?
2. Is it feasible to implement an adaptive dance program using action-observation principles for children diagnosed with Cerebral Palsy (CP)? Participants will complete a pre-dance program assessment, participate in a 10-week dance program (20 hours), and complete a post-dance program assessment.

Conditions

  • Cerebral Palsy

Interventions

BEHAVIORAL

Adapted Dance Program

* Participants will attend a 2x/weekly adaptive dance session for 10 weeks. If participants miss a class due to illness or an unexpected event (loss of transportation, family emergency/need) they will receive a video of the content missed and can complete the session at home. * Each class will start with a 10 min warm-up that will include stretching and motor games. * Learn a section of choreography every session using action-based intervention for 30 minutes. * Break for 5 min. * Improvisation part of class for 10 min. * Cool-down for 5 min.

Sponsors & Collaborators

  • Texas Scottish Rite Hospital for Children

    lead OTHER

Principal Investigators

  • Michelle Christie, MD · Scottish Rite for Children

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-22
Primary Completion
2026-08-31
Completion
2027-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06100562 on ClinicalTrials.gov